GlycoMark, Inc. is a joint venture among Toyota Tsusho America, Inc. (New York, NY), Toyota Tsusho Corporation (Tokyo, Japan) and Nippon Kayaku Co., Ltd. (Tokyo, Japan) and is dedicated to the discovery and commercialization of novel biomarkers for diabetes.
The GlycoMark 1,5-anhydroglucitol biomarker was originally discovered to be linked to diabetes by a Japanese researcher in the 1980s and since its discovery, over 40 clinical trials have been completed using the marker around the world. The test has been used since the early 1990s in Japan and is a standard glycemic biomarker in that country.
Nippon Kayaku, Co., Ltd, a large pharmaceutical and biochemical manufacturer in Japan is the manufacturer of the GlycoMark test, Toyota Tsusho Corporation imports the GlycoMark test from Japan and provides the commercialization support for the product through GlycoMark, Inc.
805 Third Avenue, 17th Floor
New York, NY 10022
Customer Service Questions or Comments?
Fax: (212) 355-8165